Tenax Therapeutics TENX
NASDAQ TENX
$1.75 -0.03 (-1.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Finished Goods (2012 - 2014)

Tenax Therapeutics (TENX) posted quarterly Finished Goods of $68658.0 for Q1 2014, down 13.27% year-over-year from $79159.0 in Q1 2013, and down 0.79% on a QoQ basis from $69206.0 in Q4 2013.

Tenax Therapeutics (TENX) Finished Goods (2012 - 2014) Analysis & Trends

Tenax Therapeutics has reported Finished Goods for 3 years, with the latest figure at $68658.0 in Q1 2014.

  • Finished Goods for Q1 2014 came in at $68658.0, down 13.27% year-over-year; the trailing twelve-month figure through Jan 2014 was $68658.0 (down 13.27% YoY), and the FY2013 annual result was $70425.0, up 21.86% from the prior year.
  • Finished Goods declined to $68658.0 in Q1 2014, from $69206.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $80578.0 in Q4 2012 and troughed at $49480.0 in Q3 2012.
  • A 3-year average of $68181.8 and a median of $69681.5 in 2013 frame the typical range for Finished Goods.
  • The largest YoY upside for Finished Goods was 41.79% in 2013 against a maximum downside of 14.11% in 2013.
  • A 3-year view of Finished Goods shows it stood at $80578.0 in 2012, then dropped by 14.11% to $69206.0 in 2013, then decreased by 0.79% to $68658.0 in 2014.
  • Per Business Quant data, the three most recent Finished Goods figures were $68658.0 in Q1 2014, $69206.0 in Q4 2013, and $70157.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Tenax Therapeutics 78.47 Mn 78.47 Mn -

Historic Data

Download Data
DateValue
Jan 31, 2014 68,658.00
Oct 31, 2013 69,206.00
Jul 31, 2013 70,157.00
Apr 30, 2013 70,425.00
Jan 31, 2013 79,159.00
Oct 31, 2012 80,578.00
Jul 31, 2012 49,480.00
Apr 30, 2012 57,791.00